Company research / CDLX

Cardlytics, Inc. (CDLX)

CIK 0001666071 · Nasdaq · Services-Computer Programming, Data Processing, Etc.

  • Sector Services
  • Incorporated DE
  • Fiscal year ends Dec 31

For the year ended 2025-12-31, Cardlytics, Inc. reported revenue of $233.27M. Revenue fell 16.2% from the prior annual period.

Key ratios (year ended 2025-12-31)

-43.6%
Operating margin
-44.4%
Net margin
-16.2%
Revenue growth (YoY)

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: Form 4 (ownership change) · 2026-10-02

Headquarters locality: Atlanta · View on map

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. n/a means a matching observation is unavailable. Free cash flow is operating cash flow minus capital expenditures, and EBITDA is operating income plus depreciation and amortization, for the same period, computed by TickerFacts.

The first column covers the twelve months to 2026-06-30 from the latest quarterly report: flows are the last fiscal year plus this year to date minus the same months a year earlier, and balances are as of that date. Per-share figures are annual only.

Stock splits: 1-for-10, first reflected in a filing dated 2026-08-05. Figures are as filed: per-share figures and share counts last reported before a split are on the old share basis, so changes and growth rates across a split are not shown. Splits are read from the filings' own restatements, so a share conversion in a merger or reorganization shows up the same way.

Period endedTTM to
2026-06-30
2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
Revenuen/a$233.27M$278.30M$309.20M$298.54M$267.12M$186.89M$210.43M$150.68M$130.37M$112.82M
R&D Expensen/a$39.77M$49.61M$51.35M$54.44M$38.10M$17.53M$11.70M$16.21M$12.15M$13.90M
Operating Incomen/a-$101.82M-$195.50M-$135.67M-$457.78M-$122.60M-$53.92M-$17.32M-$40.92M-$17.10M-$56.23M
Depreciation & Amortization$21.16M$25.24M$25.69M$26.46M$37.54M$29.87M$7.83M$4.54M$3.28M$3.03M$4.22M
EBITDAn/a-$76.57M-$169.81M-$109.21M-$420.23M-$92.73M-$46.10M-$12.79M-$37.63M-$14.07M-$52.01M
Net Income-$100.28M-$103.49M-$189.30M-$134.70M-$465.26M-$128.56M-$55.42M-$17.14M-$53.04M-$19.64M-$75.70M
EPS (Diluted)n/a-$1.95-$3.91-$3.69-$13.92n/an/an/an/an/an/a
Total Assets$234.78M$285.64M$392.71M$574.14M$691.24M$1.26B$422.54M$224.31M$153.76M$100.76Mn/a
Total Liabilities$250.79M$292.15M$322.72M$439.35M$479.63M$573.10M$265.35M$81.05Mn/an/an/a
Long-Term Debt$184.41M$212.57M$218.57Mn/a$226.04M$184.40M$174.01Mn/a$46.66Mn/an/a
Shareholders' Equity-$16.00M-$6.51M$69.99M$134.80M$211.60M$690.70M$157.19M$143.27M$51.98M-$208.69M-$216.84M
Cash & Equivalents$28.04M$48.72M$65.59M$91.83M$121.91M$233.47M$293.24M$104.46M$39.62M$21.26M$22.84M
Operating Cash Flow$532.0K$9.29M-$8.82M-$185.0K-$53.90M-$38.52M-$7.60M$11.46M-$19.00M-$22.10M-$32.50M
Capital Expenditures$69.0K$480.0K$1.56M$667.0K$1.17M$3.11M$5.41M$8.28M$5.92M$1.22M$1.83M
Free Cash Flow$463.0K$8.81M-$10.39M-$852.0K-$55.08M-$41.63M-$13.01M$3.18M-$24.91M-$23.32M-$34.33M
Share Repurchasesn/an/a$0$0$40.00M$0$0n/an/an/an/a
Shares Outstanding5.45M54.51M51.26M39.73Mn/an/an/an/a22.47M3.44Mn/a
Weighted Average Diluted Sharesn/a53.11M48.36M36.49M33.42Mn/an/an/an/an/an/a
EPS (Basic)n/a-$1.95-$3.91-$3.69-$13.92-$3.99-$2.04n/an/an/an/a

Price chart

Chart and quotes by TradingView. Exchange coverage and delays vary.

Open chart on TradingView